Huanbai Xu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- Biomarkers in Disease Mechanisms 3
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 4
-
- Chemokine receptors and signaling 3
-
- Ferroptosis and cancer prognosis 4
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Tao TaoMin JinQiong WuYuqing ChenFeng QianBing WanYaxue ZhaoQing Liang
- Journals
- Advances in experimental medicine and biology (3 papers)BMC Cancer (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
- Partner nations
- ChinaUnited StatesSri Lanka
In The Last Decade
Huanbai Xu
33 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 240
- Immunology 184
- Molecular Biology 558
- Genetics 71
- Oncology 175
Countries citing papers authored by Huanbai Xu
This map shows the geographic impact of Huanbai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanbai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanbai Xu more than expected).
Fields of papers citing papers by Huanbai Xu
This network shows the impact of papers produced by Huanbai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanbai Xu. The network helps show where Huanbai Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huanbai Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 33 | |
| 5 | 2020 | 3 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 138 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 24 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 12 | |
| 13 | 2016 | 14 | |
| 14 | 2014 | 98 | |
| 15 | 2014 | 49 | |
| 16 | 2011 | 41 | |
| 17 | 2011 | 49 | |
| 18 | 2010 | 19 | |
| 19 | 2010 | 57 | |
| 20 | 2008 | 45 |
About Huanbai Xu
Huanbai Xu is a scholar working on Cancer Research, Immunology and Toxicology, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), Autophagy in Disease and Therapy (4 papers), Biomarkers in Disease Mechanisms (3 papers), MicroRNA in disease regulation (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Cancer Research (240 citations), Immunology (184 citations) and Molecular Biology (558 citations). Huanbai Xu has collaborated with scholars based in China, United States and Sri Lanka. Frequent co-authors include Tao Tao, Min Jin, Qiong Wu, Yuqing Chen, Feng Qian, Bing Wan, Yaxue Zhao, Qing Liang, Daijie Chen and Yanyun Zhang. Their work appears in journals such as Advances in experimental medicine and biology, BMC Cancer, The Journal of Clinical Endocrinology & Metabolism, Autophagy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.